Search results for "Infectious Diseases"
HCV treatment by NPs, PCPs appears safe, effective as that provided by subspecialists
Reversing restrictions that limit prescribing of direct-acting antivirals might allow rapid escalation of safe, effective therapy for hepatitis C virus (HCV) infection and could improve the care of patients, study authors noted.
https://acpinternist.org/weekly/archives/2017/08/08/2.htm
8 Aug 2017
Joint guidelines issued for drug-susceptible pulmonary tuberculosis
A 4-drug regimen of isoniazid, rifampin, pyrazinamide, and ethambutol, followed by a continuation phase of 4 months of isoniazid and rifampin, remains the preferred initial treatment.
https://acpinternist.org/weekly/archives/2016/08/16/5.htm
16 Aug 2016
Antibiotic stewardship improved prescribing for suspected UTI in frail older adults
Inappropriate antibiotic prescribing for suspected urinary tract infections (UTIs) was reduced in practices and facilities assigned to use a decision tool instead of usual care, particularly for patients with dementia, a randomized trial in Europe found.
https://acpinternist.org/weekly/archives/2023/02/28/5.htm
28 Feb 2023
CDC and FDA weigh in on safety of bivalent vaccine; research examines COVID-19 sequelae, omicron variants
The CDC and FDA said an observed association of ischemic stroke with the Pfizer-BioNTech bivalent booster is very unlikely to represent a true clinical risk. New studies reported on symptoms a year after mild COVID-19 and estimated protection against the omicron variants.
https://acpinternist.org/weekly/archives/2023/01/24/2.htm
24 Jan 2023
ACP, Annals of Internal Medicine host ‘Monkeypox: Challenging Clinical Questions’
The virtual forum featured a panel of physicians providing answers to commonly asked questions about the human monkeypox virus and is available for replay online.
https://acpinternist.org/weekly/archives/2022/10/18/5.htm
18 Oct 2022
Register now for ACP and Annals of Internal Medicine's latest forum, ‘Monkeypox: Challenging Clinical Questions'
During the Oct. 11 virtual live event, experts will discuss and provide answers to questions about the human monkeypox virus that physicians are facing today.
https://acpinternist.org/weekly/archives/2022/10/04/2.htm
4 Oct 2022
IDSA offers guidance on managing drug interactions with nirmatrelvir/ritonavir
The Infectious Diseases Society of America (IDSA) listed six steps to help clinicians prescribe the COVID-19 medication while minimizing interaction risks. Other recent research looked at neuropsychiatric conditions after COVID-19 and hospital profits during the pandemic.
https://acpinternist.org/weekly/archives/2022/05/17/2.htm
17 May 2022
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://acpinternist.org/archives/2021/05/latest-updates-on-acps-priorities-initiatives.htm
1 May 2021
Trio of plenary speakers offers hope, humanity, healing
Plenary speakers Anthony S. Fauci, MD, Kimberly Manning, MD, FACP, and Rana Awdish, MD, FACP, reflected on the COVID-19 pandemic and systemic racism in the United States and offered ways to move forward.
https://acpinternist.org/archives/2021/06/trio-of-plenary-speakers-offers-hope-humanity-healing.htm
1 Jun 2021
IDSA issues updated guidelines on infectious diarrhea
Among the recommendations, physicians should obtain a detailed clinical exposure history from all people with diarrhea, including when there is a similar history in other patients, and patients who have fever or bloody diarrhea should be evaluated for enteropathogens that may respond to antimicrobial agents.
https://acpinternist.org/weekly/archives/2017/10/24/1.htm
24 Oct 2017